Oscillating Positive Expiratory Pressure Device for Rib Fractures

N/A

Recruiting

Led By Julie Dunn, MD

Research Sponsored by Poudre Valley Health System

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 times daily, until fvc is >1.5 liters x 4 consecutive tests, or up to 4 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial compares OPEP therapy to IS in patients admitted for rib fractures.

Eligible Conditions

Rib Fractures
Respiratory Complications
Traumatic Rib Fracture(s)

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 times daily, until fvc is >1.5 liters x 4 consecutive tests, or up to 4 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 times daily, until fvc is >1.5 liters x 4 consecutive tests, or up to 4 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 times daily, until fvc is >1.5 liters x 4 consecutive tests, or up to 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Time (hours) to stable forced vital capacity

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Oscillating Positive Expiratory Pressure DeviceExperimental Treatment1 Intervention

Each patient will be instructed on how to use the respiratory therapy device, either IS or OPEP, by research personnel and respiratory therapists. Participants will be instructed to record their compliance with the RT protocol in their respective patient diaries. Patient diaries will be collected upon discharge for analysis.

Group II: Incentive spirometryActive Control1 Intervention

Do I qualify?Apply below to find out